AstraZeneca is renewing efforts to tackle stigma and amp awareness of COPD this month. (Shutterstock)
November 9, 2022 02:10 PM ESTUpdated November 10, 08:40 AM
Pharma
Marketing

As­traZeneca dou­bles down on COPD aware­ness ef­forts dur­ing na­tion­al aware­ness month

Beth Snyder Bulik

Senior Editor

More than half of peo­ple liv­ing with chron­ic ob­struc­tive pul­monary dis­ease in the US are un­di­ag­nosed. It’s not a brand new prob­lem, but it’s one …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Drug or bi­o­log­ic? An Eli Lil­ly law­suit could im­pact weight loss drug com­pounders

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Sur­round­ed by AI bio gi­ants, tiny start­up Nabla Bio makes de no­vo an­ti­bod­ies look more like drugs 

From vac­cines to psy­che­delics, five drug­mak­ers on what could change un­der a Trump ad­min­is­tra­tion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times